Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Cadila&nbsp;Healthcare&nbsp;Ltd.&nbsp;plans to submit trial data for its Covid-19 vaccine by end of May and is looking for an approval in June, Financial Express&nbsp;reported&nbsp;citing Sharvil Patel, managing director of Cadila.
The Phase-III clinical trials of the ZyCoV-D vaccine will be representative of its efficacy against many known variants as different ones have surfaced in this wave, Patel told Financial Express.&nbsp;
India's Cadila Healthcare has started producing its potential COVID-19&nbsp;vaccine last month for which it will seek emergency use authorisation in May or June, with an aim to make up to 240 million doses a year.

India’s Cadila Healthcare eyes approval for Covid-19 vaccine by June

Cadila&nbsp;to&nbsp;submit trial data for its Covid-19 vaccine by end of May
Cadila to make up to 240 mn doses annually, if approved
Cadila also seeking nod to administer its vaccine to children
&nbsp;

Cadila&nbsp;Healthcare&nbsp;Ltd.&nbsp;plans to submit trial data for its Covid-19 vaccine by end of May and is looking for an approval in June, Financial Express&nbsp;reported&nbsp;citing Sharvil Patel, managing director of Cadila.
The Phase-III clinical trials of the ZyCoV-D vaccine will be representative of its efficacy against many known variants as different ones have surfaced in this wave, Patel told Financial Express.&nbsp;
Cadila Healthcare&nbsp;started producing its potential Covid-19&nbsp;vaccine last month for which it will seek emergency use authorisation in May or June, with an aim to make up to 240 million doses a year.

vaccine certificate

Categories